The mechanisms of proteinuria development in preeclampsia (PE) are still enigmatic. Renin–angiotensin system (RAS) components may play a role. Maternal serum and urinary concentrations of angiotensin-(1-7) [Ang-(1-7)], angiotensin II (Ang II), and angiotensinogen in women with PE (n = 14), gestational hypertension (n = 14), and normal pregnancy were quantified. The alteration in these concentrations was used to evaluate their relationships with podocyturia and proteinuria in PE. In addition, the podocytes cultured in vitro were interfered in serum of preeclamptic and normotensive pregnant women, with or without Ang-(1-7). The morphologic change in podocyte was observed using a microscope. The changes in podocyte-specific proteins (nephrin, CD2-associated protein [CD2AP]), the cytoskeletal protein F-actin, the tight junction protein (ZO-1), and Mas receptor (MasR) were examined by immunofluorescence. Western blot was used to examine the expression and variation of MasR. We found that the concentrations of RAS components were associated with prepartal urinary podocyte number, random urine albumin/creatinine ratio, blood pressure, and renal function. The expression of nephrin, F-actin, ZO-1, and MasR on podocytes interfered in serum of PE was significantly decreased compared to normal control and normal pregnant serum group in vitro, yet their expression was significantly increased after coculture by 10−6 mol/L Ang-(1-7) and the preeclamptic serum. The expression of CD2AP had no significant difference. We concluded that decreased Ang-(1-7) and downregulated intrarenal RAS contributed to the direct podocyte injury with proteinuria in PE.
Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–S22.
2.
CraiciMIWagnerSJWeissgerberTLGrandeJPGarovicVD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014;86(2):275–285.
3.
ZhaoSGuXGroomeLJWangY. Decreased Nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod Sci. 2009;16(10):970–979.
4.
ChenGZhangLJinX, et al.Effects of angiogenic factors, antagonists and podocyte injury on development of proteinuria in preeclampsia. Reprod Sci. 2013;20(5):579–588.
5.
UddinMNAgunanneEHorvatDPuschettJB. Alterations in the renin-angiotensin system in a rat model of human preeclampsia. Am J Nephrol. 2010;31(2):171–177.
6.
IraniRAXiaY. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29(9):763–771.
7.
LaraLSBicaRBSenaSL, et al.Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor. Regul Pept. 2002;103(1):17–22.
8.
Lara LdaSCavalcanteFAxelbandFDe SouzaAMLopesAGCaruso-NevesC. Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7). Biochem J. 2006;395(1):183–190.
9.
FerrarioCMTraskAJJessupJA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005;289(6):H2281–H2290.
10.
SantosRAFerreiraAJPinheiroSVSampaioWOTouyzRCampagnole-SantosMJ. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs. 2005;14(8):1019–1031.
11.
KarnikSSUnalHKempJR, et al.International union of basic and clinical pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli. Pharmacol Rev. 2015;67(4): 754–819.
12.
SantosRAFerreiraAJSimoesESAC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol. 2008;93(5):519–527.
LantelmePRohrwasserAVincentM, et al.Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens. 2005;23(4):785–792.
15.
PringleKGSykesSDLumbersER. Circulating and intrarenal renin–angiotensin systems in healthy men and nonpregnant women. Physiol Rep. 2015;3(10):e12586.
16.
MundelPReiserJZúñiga Mejía BorjaA, et al.Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res. 1997;236(1):248–258.
17.
MundelPReiserJKrizW. Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol. 1997;8(5):697–705.
18.
MirzaFGClearyKL. Pre-eclampsia and the kidney. Semin Perinatol. 2009;33(3):173–178.
19.
HenaoDEMathiesonPWSaleemMABuenoJCCadavidA. A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant. 2007;22(5):1477.
20.
Simoes e SilvaACPinheiroSVPereiraRMFerreiraAJSantosRA. The therapeutic potential of angiotensin-(1-7) as a novel renin-angiotensin system mediator. Mini Rev Med Chem. 2006;6(5):603–609.
21.
NogueiraAISouza SantosRASimoesESAC, et al.The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes. Regul Pept. 2007;141(1-3):55–60.
22.
BrosnihanKBNevesLAJoynerJ, et al.Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension. 2003;42(4):749–753.
23.
NevesLAWilliamsAFAverillDBFerrarioCMWalkupMPBrosnihanKB. Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology. 2003;144(8):3338–3343.
24.
ValdesGGermainAMCorthornJ, et al.Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine. 2001;16(2):117–122.
25.
VellosoEPVieiraRCabralACKalapothakisESantosRA. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype. Braz J Med Biol Res. 2007;40(4):583–590.
26.
ShahDM. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol. 2005;288(4):F614–F625.
27.
KoboriHAlperABJrShenavaR, et al.Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53(2):344–350.
28.
UrushiharaMKondoSKagamiSKoboriH. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol. 2010;31(4):318–325.
29.
KoboriHOhashiNKatsuradaA, et al.Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2(5):349–354.
30.
OhashiNYamamotoTHuangY, et al.Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats. Am J Physiol Renal Physiol. 2008;295(5):F1512–F1518.
31.
YamamotoTNakagawaTSuzukiH, et al.Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18(5):1558–1565.
32.
AhnSYKimSKimDK, et al.Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease. J Korean Med Sci. 2014;29 suppl (2):S123–S130.
33.
KoboriHPrieto-CarrasqueroMCOzawaYNavarLG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension. 2004;43(5):1126–1132.
34.
AitaKEtohMHamadaH, et al.Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract. 2009;112(2):c65–c70.
35.
VermaRVenkatareddyMKalinowskiAPatelSRSalantDJGargP. Shp2 associates with and enhances nephrin tyrosine phosphorylation and is necessary for foot process spreading in mouse models of podocyte injury. Mol Cell Biol. 2016;36(4):596–614.
36.
SchwarzKSimonsMReiserJ, et al.Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001;108(11):1621–1629.
37.
HulthenUL. Nephrin: a pivotal molecule in proteinuria influenced by angiotensin II. J Hypertens. 2003;21(1):39–40.
38.
CohenMPChenSZiyadehFN, et al.Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int. 2005;68(4):1554–1561.
39.
HsuHHHoffmannSDi MarcoGS, et al.Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II–mediated podocyte apoptosis. Kidney Int. 2011;80(9):959–969.
40.
TianJZhangLZhouY, et al.Angiotensin-(1-7) attenuates damage to podocytes induced by preeclamptic serum through MAPK pathways. Int J Mol Med. 2014;34(4):1057–1064.
41.
FaulCAsanumaKYanagida-AsanumaEKimKMundelP. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007;17(9):428–437.
42.
ShanklandSJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69(12):2131–2147.
43.
KodaRYoshinoAImanishiY, et al.Expression of tight junction protein claudin-1 in human crescentic glomerulonephritis [published online April 27, 2014]. Int J Nephrol. 2014.
44.
FanningASMaTYAndersonJM. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. Faseb J. 2002;16(13):1835–1837.
45.
KawachiHKuriharaHTophamPS, et al.Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol. 1997;273(6 Pt 2):F984–F993.
46.
GerkePHuberTBSellinLBenzingTWalzG. Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1. J Am Soc Nephrol. 2003;14(4):918–926.
47.
KostenisEMilliganGChristopoulosA, et al.G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation. 2005;111(14):1806–1813.
